Latvia vs Naoero: Immunization, Hib3
Latvia
97.0%
in 2024
Naoero
97.0%
in 2024
Latvia rank
29th
Naoero rank
29th
Immunization, Hib3 over time
- Latvia
- Naoero
How they compare
Latvia currently reports 97.0% against 97.0% in Naoero, a difference of 0.0%.
The two have swapped places 6 times across 16 shared years of data; in 2009 it was Naoero ahead.
Latvia ranks 29th and Naoero ranks 29th of 191 countries.
Across the 3 decades both report, Latvia averaged higher in 1 and Naoero in 2.
Head to head by decade
| Decade | Latvia | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.0% | 99.0% | 5.0% | Naoero |
| 2010s | 94.2% | 92.0% | 2.2% | Latvia |
| 2020s | 96.4% | 96.8% | 0.4% | Naoero |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Latvia or Naoero?
- Latvia, at 97.0% against 97.0% in Naoero as of 2024.
- What is the difference in immunization, hib3 between Latvia and Naoero?
- 0.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Naoero?
- 16 years are reported by both, from 2009 to 2024.
- How do Latvia and Naoero rank globally for immunization, hib3?
- Latvia ranks 29th and Naoero ranks 29th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.